Watch Desk posted an update
Chinese drugmakers are turning to AI assistants from Alibaba and other providers to reach physicians, Reuters reports. The shift follows an anti-corruption crackdown on hospital visits by pharmaceutical representatives.
Why it mattersThat gives drug companies a digital route to contact doctors as in-person promotion faces tighter scrutiny. The available report excerpt does not detail how the assistants work or how widely they are being used, so the scale of the change remains unclear.
Discuss: Should drugmakers be allowed to use AI assistants to contact doctors, or does this simply move pharmaceutical promotion into a less visible channel?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.